Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin.
Rachel JeongRobert R QuinnKrista L LentinePietro RavaniFeng YePatricia CampbellKevin WenChris BroscheitSita GourishankarNgan N LamPublished in: Canadian journal of kidney health and disease (2020)
Not applicable (cohort study).